1. Home
  2. STGW vs IMTX Comparison

STGW vs IMTX Comparison

Compare STGW & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stagwell Inc.

STGW

Stagwell Inc.

HOLD

Current Price

$6.89

Market Cap

1.7B

Sector

N/A

ML Signal

HOLD

Logo Immatics N.V.

IMTX

Immatics N.V.

HOLD

Current Price

$9.17

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STGW
IMTX
Founded
1980
N/A
Country
United States
Germany
Employees
N/A
407
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
STGW
IMTX
Price
$6.89
$9.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
6
Target Price
$8.39
$19.00
AVG Volume (30 Days)
1.4M
503.0K
Earning Date
04-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,909,000,000.00
N/A
Revenue This Year
$13.27
N/A
Revenue Next Year
$4.07
$25.91
P/E Ratio
N/A
N/A
Revenue Growth
2.39
N/A
52 Week Low
$4.29
$5.05
52 Week High
$7.52
$12.41

Technical Indicators

Market Signals
Indicator
STGW
IMTX
Relative Strength Index (RSI) 57.25 35.89
Support Level $4.94 $8.97
Resistance Level $7.02 $10.64
Average True Range (ATR) 0.31 0.54
MACD -0.00 -0.13
Stochastic Oscillator 53.94 13.63

Price Performance

Historical Comparison
STGW
IMTX

About STGW Stagwell Inc.

Stagwell Inc is a challenger network using AI to deliver marketing and advertising solutions to its clients. It operates in five reportable segments: Marketing Services, Digital Transformation, Media and Commerce, Communications, and The Marketing Cloud. Maximum revenue is generated from the Marketing Services segment, which offers social media solutions, designs breakthrough brand campaigns, and creates immersive experiential marketing programs and social engagement strategies, helping clients connect with audiences across digital platforms. The various brands operating under this segment include 72 and Sunny, Anomaly, NRG, Harris Insights, TEAM, and Movers & Shaker. Geographically, the company generates maximum revenue from the United States, followed by the UK and other countries.

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: